doi: 10.1080/07388551.2016.1260525 32 AbeciaJAMeikleAVzquezMICasaoAForcadaFSosaC
Experimental observations indicate that DSIP may influence slow-wave sleep dynamics and sleep onset latency, making it a useful tool for investigating mechanisms underlying restorative sleep phases [1]
To test this, we calculated the NTS-to-AP FOS ratio for each treatment
Several factors can shift your needs: Activity level : If you exercise regularly, especially resistance training, you may benefit from the higher end of the range
Real-World Results For GLP-1 Drugs Underwhelm, Study Says WEDNESDAY, June 11, 2025 (HealthDay News) Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and Zepbound arent as impressive as those promised by the drugs clinical trials, a new study says.People taking such GLP-1 drugs lost just under 9% of their body weight on average after a year, researchers reported June 10 in the journal Obesity.Thats far less than the 15% to 21% body weight reduction promised by the clinical trials that led to the approval of Wegovy (semaglutide) and Zepbound (tirzepatide) for weight loss, researchers said.Patients treated for obesity with semaglutide or trizepatide lost less weight on average in a regular clinical setting compared to what is observed in randomized clinical trial, lead investigator Hamlet Gasoyan said in a news release
